CCK-B Receptor Antagonist 1 (Synonyms: (Rac)-Netazepide; (Rac)-YF 476; (Rac)-YM-220) |
| Katalog-Nr.GC30752 |
CCK-B-Rezeptorantagonist 1 ist ein Antagonist des Cholecystokinin B (CCK-B)-Rezeptors und hat das Potenzial, die Sekretion von MagensÄure zu reduzieren.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 168161-71-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CCK-B Receptor Antagonist 1 is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.
CCK-B Receptor Antagonist 1 is an antagonist of CCK-B receptor, and has the potential of reducing the secretion of gastric acid[1].
[1]. Hamish Ryder, et al. Benzodiazepin derivatives useful as cck-receptor antagonists. WO 1993016999 A1.
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *